120 related articles for article (PubMed ID: 28150409)
41. Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.
De Brot L; Pellegrini B; Moretti ST; Carraro DM; Soares FA; Rocha RM; Baiocchi G; da Cunha IW; de Andrade VP
Cancer Cytopathol; 2017 Feb; 125(2):138-143. PubMed ID: 27870295
[TBL] [Abstract][Full Text] [Related]
42. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors.
Wang HY; Park S; Kim S; Lee D; Kim G; Kim Y; Park KH; Lee H
Am J Clin Pathol; 2015 Mar; 143(3):344-51. PubMed ID: 25696792
[TBL] [Abstract][Full Text] [Related]
43. HPV detection rates and histopathologic follow-up of patients with HSIL cytology in a large academic women's hospital laboratory.
Ashman D; Zhang H; Li J; Austin M; Wang T; Pradhan D; Zhao C
J Am Soc Cytopathol; 2020; 9(6):550-555. PubMed ID: 32475726
[TBL] [Abstract][Full Text] [Related]
44. Telomerase and human papillomavirus as diagnostic adjuncts for cervical dysplasia and carcinoma.
Jarboe EA; Thompson LC; Heinz D; McGregor JA; Shroyer KR
Hum Pathol; 2004 Apr; 35(4):396-402. PubMed ID: 15116318
[TBL] [Abstract][Full Text] [Related]
45. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
[TBL] [Abstract][Full Text] [Related]
46. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
[TBL] [Abstract][Full Text] [Related]
47. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
[TBL] [Abstract][Full Text] [Related]
48. Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer.
Carrillo-García A; Ponce-de-León-Rosales S; Cantú-de-León D; Fragoso-Ontiveros V; Martínez-Ramírez I; Orozco-Colín A; Mohar A; Lizano M
Gynecol Oncol; 2014 Sep; 134(3):534-9. PubMed ID: 24979052
[TBL] [Abstract][Full Text] [Related]
49. p16(INK4A) is a surrogate biomarker for a subset of human papilloma virus-associated dysplasias of the uterine cervix as determined on the Pap smear.
Bose S; Evans H; Lantzy L; Scharre K; Youssef E
Diagn Cytopathol; 2005 Jan; 32(1):21-4. PubMed ID: 15584047
[TBL] [Abstract][Full Text] [Related]
50. Detection of human herpesvirus 6 (HHV-6) and human herpesvirus 7 (HHV-7) DNA in endocervical samples from a positive and negative HPV woman of Córdoba, Argentina.
Biganzoli P; Frutos MC; Venezuela F; Mosmann J; Kiguen A; Pavan J; Ferreyra L; Cuffini C
J Clin Pathol; 2020 Jan; 73(1):30-34. PubMed ID: 31315894
[TBL] [Abstract][Full Text] [Related]
51. Role of Ancillary Techniques in Cervical Biopsy and Endocervical Curettage Specimens as Follow-Up to Papanicolaou Test Results Indicating a Diagnosis of Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion, or High-Grade Squamous Intraepithelial Lesion.
Jenkins TM; Shojaei H; Song SJ; Schwartz LE
Acta Cytol; 2020; 64(1-2):155-165. PubMed ID: 30982025
[TBL] [Abstract][Full Text] [Related]
52. Possible high-grade squamous intraepithelial lesion (pHSIL) in the new cervical screening paradigm: The outcomes and the role of clinicopathological review.
McGauran MFG; Pendlebury AB; Hiscock RJ; Lamont JM; Jones APM; Grant P; Newman MR; Ireland-Jenkin K; McGrath S; Pham K; Hyde S
Aust N Z J Obstet Gynaecol; 2021 Aug; 61(4):569-575. PubMed ID: 33939180
[TBL] [Abstract][Full Text] [Related]
53. Deceiving high-grade cervical dysplasias identified as human papillomavirus non-16 and non-18 types by Invader human papillomavirus assays.
Kitahara S; Chan RC; Nichols WS; Silva EG
Ann Diagn Pathol; 2012 Apr; 16(2):100-6. PubMed ID: 22197542
[TBL] [Abstract][Full Text] [Related]
54. Significance of bizarre cells in cervical screening liquid-based cytology: A prospective study of 15 cases.
Ondič O; Ferko R; Kičinová J; Bouda J; Kinkorová-Luňáčková I; Kupcová L; Zůchová M; Chytra J; Waloschek T; Tůmová Bartošková M; Alaghehbandan R; Němcová J
Cytopathology; 2018 Feb; 29(1):58-62. PubMed ID: 29154448
[TBL] [Abstract][Full Text] [Related]
55. Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.
Theelen W; Speel EJ; Herfs M; Reijans M; Simons G; Meulemans EV; Baldewijns MM; Ramaekers FC; Somja J; Delvenne P; Hopman AH
Am J Pathol; 2010 Oct; 177(4):2022-33. PubMed ID: 20813962
[TBL] [Abstract][Full Text] [Related]
56. Low-grade squamous intraepithelial lesion, cannot rule out high-grade lesion: Diagnosis, histological outcomes and human papillomavirus results.
Segura SE; Ramos-Rivera G; Hakima L; Suhrland M; Khader S
Cytopathology; 2019 Jan; 30(1):99-104. PubMed ID: 30187975
[TBL] [Abstract][Full Text] [Related]
57. [The usefulness of p16INK4a in cytological screening of cervical carcinoma].
Li M; Cao J; Wang NP; Li LY; Li L; Qiao YL; Pan QJ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):674-7. PubMed ID: 17274373
[TBL] [Abstract][Full Text] [Related]
58. [Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].
Luo HX; Du H; Liu ZH; Zhang LJ; Wang C; Wu RF
Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):232-238. PubMed ID: 29575846
[No Abstract] [Full Text] [Related]
59. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
60. Rescreening of high-risk HPV positive Papanicolaou tests initially screened as negative is a low yield procedure in the era of HPV genotyping.
Narkcham S; Mody DR; Jones A; Thrall MJ
J Am Soc Cytopathol; 2021; 10(6):558-564. PubMed ID: 34103275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
